Dharti Proteins reported a standalone net loss of ₹14.28 lakh for the quarter ended June 30, 2026, representing a significant deterioration from the net loss of ₹4.60 lakh recorded in the corresponding quarter of the previous year. According to the company's unaudited financial results approved by the Board of Directors on July 15, 2026, this marks a substantial increase in losses compared to the same period last year. The 280% increase in losses from ₹4.60 lakh to ₹14.28 lakh demonstrates a significant deterioration in the company's financial performance. The nil revenue from operations during Q1 FY27 indicates the company's operational challenges during the quarter.
The company reported revenue from operations of ₹0.06 lakh for Q1 FY27, marking a sharp decline from ₹2.29 lakh reported in Q1 FY26. As per the company's financial results, this represents a 97% decline in revenue generation compared to the same quarter last year. The total revenue of ₹0.06 lakh for Q1 FY27 includes other income of ₹0.06 lakh, which declined significantly from ₹2.29 lakh in the previous year quarter. Quarter-on-quarter, revenue also fell from ₹0.04 lakh in Q4 FY26, indicating consistent revenue challenges across consecutive quarters.
Total expenses for the quarter ended June 30, 2026 stood at ₹14.34 lakh, representing a significant increase from ₹6.89 lakh in the same period last year. On a sequential basis, total expenses increased from ₹5.55 lakh in Q4 FY26, indicating rising operational costs despite the absence of revenue growth. Employee benefits expense stood at ₹2.64 lakh, while other expenses accounted for ₹11.70 lakh during the reported quarter. There were no exceptional or extraordinary items recorded in Q1 FY27, unlike the preceding quarter ended March 31, 2026, which saw exceptional items of ₹39.17 lakh.
The company's basic and diluted earnings per share (EPS) for Q1 FY27 was a negative ₹2.86, compared to a negative EPS of ₹0.04 in Q1 FY26 and a negative ₹9.136 in Q4 FY26. According to the unaudited financial results, this represents a significant deterioration in the company's earnings per share performance, reflecting the challenging financial conditions faced by the company during the quarter. The paid-up equity share capital remained at ₹50.00 lakh with a face value of ₹10 per share.
The statutory auditors, M/s. N. S. Nanavati & Co., Chartered Accountants, performed a limited review of the financial results in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The auditors issued an unmodified opinion on the unaudited standalone financial results. The Audit Committee reviewed the results prior to Board approval, and the financial results were prepared in compliance with the Indian Accounting Standards (Ind AS) under Section 133 of the Companies Act, 2013.